Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	993	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	2063	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	2309	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	52230	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	53567	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	55211	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	56124	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	56330	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	56524	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	58555	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	58633	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	59331	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	60578	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	60985	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	62378	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	64594	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	64847	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	65720	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	66710	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	73245	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	76159	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	79368	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	80466	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	81966	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	85814	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	85849	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	86616	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	135450	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	135950	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	138304	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	139819	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	142709	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	144309	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	146089	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	146926	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	147568	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	148083	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	148415	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	150274	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	150445	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	151260	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	151562	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	153143	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	153361	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	155077	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	157932	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	158822	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	159570	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	160272	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	160390	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	160959	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	161427	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	161894	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	161937	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	162257	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	164092	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	165897	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	166050	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	166249	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	166964	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	167013	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	167084	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	167170	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	167378	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	167794	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	168919	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	168988	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	170227	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	170515	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	171317	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	171542	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	172322	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	173257	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	173912	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	175546	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	176164	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	176266	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	177278	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	178914	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	179110	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	179191	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	179523	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	180081	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	180287	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	180531	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	181157	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	181379	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	181762	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	181765	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	182392	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	182404	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	183677	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	183880	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	184423	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	184557	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	184561	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	185294	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	185362	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	185678	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	185999	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186169	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186208	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186216	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186229	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186310	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186512	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186527	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186722	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186863	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	186969	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187015	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187026	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187081	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187112	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187331	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187428	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187444	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187512	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187557	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187646	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187665	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187675	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187728	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187892	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187960	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187976	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187990	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	187990	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188049	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188305	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188482	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188694	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188752	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188819	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	188891	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	189134	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	189270	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	189532	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	189797	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190115	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190195	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190476	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190519	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190582	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190599	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190711	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190739	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190748	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190757	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	190878	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	191009	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	191046	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	191211	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	191289	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	191631	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	191658	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	192797	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	192905	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	193003	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	194199	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	195078	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	195397	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	195447	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	195516	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	195548	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	197007	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	198726	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	199816	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	199943	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	200591	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	200701	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	200914	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	200917	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	201134	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	201255	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	201366	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	203594	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	204330	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	204662	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	204994	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	206093	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	206412	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	206520	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	206632	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	211167	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	212042	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	212090	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	212222	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	213192	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	215037	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	217371	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	217661	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	217714	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	218490	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	218513	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	218963	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	219142	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	219253	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	220987	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyridoxamine	221070	Peak area normalized	Sample	male

Return to search page